Ms. Yuan SUN

2023-01-11

Mr. Sun was appointed as a Director in April 2022 and re-designated as a non-executive Director in May 2022.

Mr. Sun has over 8 years of experience in investment management industry. He is currently investment director of CS Capital Co., Ltd. (国投招商投资管理有限公司).

Mr. Sun received his Bachelor’s degree in computer science and technology from Tsinghua University (清华大学) in China in July 2010. He received his Master’s degree in finance from Washington University in St. Louis in the United States in December 2012. He obtained the Chartered Financial Analyst qualification in November 2017.

Last:none

Next:Ms. Dongmei JI

Back

Media contact

e-mail:communication@laekna.com

Recommendation

2024-11-20

Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obesity
More
2024-06-26

Laekna Announces First Subject Dosed in Phase I Clinical Trial of LAE102 (a monoclonal antibody against ActRIIA) in China for The Treatment of Obesity
More

RSS Feeds

If you want to know more about Laekna, please fill in the form below and sign up for emails: